Wire · opportunities
Abbott receives US FDA approval to treat challenging AF cases with TactiFlex Duo ablation catheter
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 15 September 2026 · Fusion42 review
Abbott has received FDA approval for the TactiFlex Duo ablation catheter to treat challenging atrial fibrillation cases using dual-energy pulsed field and radiofrequency ablation, supporting tailored treatment with precision and flexibility.
This Wire brief sits within Fusion42's coverage of Medtech, and 5 sources have reported it between 8 Sep 2026 and 15 Sep 2026.
◆ ◆ The Wire takeaway
You have a new door open in the US for delivering more precise AF treatments with hybrid energy catheters. Get ready to engage electrophysiologists seeking flexible tools that cut treatment risk and improve patient outcomes.
◆ Coverage
5 sources · first reported 8 Sep 2026 · latest 15 Sep 2026
◆ Related on Wire
◆ Topics